Art Vandelay
Senior Member (Voting Rights)
Some good news:
Count ME: A Milestone for ME/CFS Recognition in Australia
In a groundbreaking development for the myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) community, ME/CFS will be included in the upcoming Australian Burden of Disease Study (ABDS), set to be released by the Australian Institute of Health and Welfare (AIHW) in December 2026. This marks the first time since 2003 that ME/CFS will be recognised as a separate condition within the national health framework, a pivotal moment that promises to reshape the landscape of public health for over 250,000 Australians.
The ABDS is the nation’s definitive guide for assessing the impact of various diseases and health conditions on the Australian population. By utilising Disability-Adjusted Life Years (DALYs), the study provides a comprehensive measure of health loss, allowing for direct comparisons across a wide spectrum of health issues.
Count ME: A Milestone for ME/CFS Recognition in Australia
In a groundbreaking development for the myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) community, ME/CFS will be included in the upcoming Australian Burden of Disease Study (ABDS), set to be released by the Australian Institute of Health and Welfare (AIHW) in December 2026. This marks the first time since 2003 that ME/CFS will be recognised as a separate condition within the national health framework, a pivotal moment that promises to reshape the landscape of public health for over 250,000 Australians.
The ABDS is the nation’s definitive guide for assessing the impact of various diseases and health conditions on the Australian population. By utilising Disability-Adjusted Life Years (DALYs), the study provides a comprehensive measure of health loss, allowing for direct comparisons across a wide spectrum of health issues.
